Around 130 delegates across Provinces, professionals, and support groups heard the latest research at the Chaps/Tackle/Masonic (CTM) Prostate Cancer Screening Conference in Freemasons’ Hall on 26 March. Prostate cancer is now our most common cancer and the second most common cause of male cancer deaths. There are 56,000 cases and 13,000 deaths every year, with numbers rising.
The objectives of the event were to present the latest evidence from prostate cancer screening in the UK and Europe, to demonstrate the considerable benefits of screening to a national audience, and to present the latest outcomes and benefits of the CTM and UK screening projects.
The conference promoted the roll-out of screening and the CTM programmed protocol. Comprehensive prostate cancer screening is proven to reduce mortality substantially, with PSA-based screening programmes in Europe and the USA halving the death rate from the disease.
